2005
DOI: 10.1097/01.mib.0000187980.08686.18
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of 4 Neutrophil-Derived Proteins in Feces As Indicators of Disease Activity in Ulcerative Colitis

Abstract: Among the neutrophil-derived proteins in feces, PMN-e, Cal, and Lf represent useful markers of disease activity in patients with UC. Using all 3 markers in a composite index may be an additional noninvasive tool for the management of ambulant patients with UC.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
85
1
4

Year Published

2007
2007
2017
2017

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 130 publications
(96 citation statements)
references
References 34 publications
6
85
1
4
Order By: Relevance
“…In human studies, measurement of neutrophil markers, including MPO and other granule proteins and chemokines, in fecal contents and intestine lavage, is used for diagnosis and to monitor therapy and correlate well with other parameters, such as endoscopic grade of inflammation [41][42][43][44][45][46]. In mice, macrophages do not express MPO; only neutrophils do [47,48].…”
Section: Altered Neutrophil Influx In Mmp7 −/− Micementioning
confidence: 99%
“…In human studies, measurement of neutrophil markers, including MPO and other granule proteins and chemokines, in fecal contents and intestine lavage, is used for diagnosis and to monitor therapy and correlate well with other parameters, such as endoscopic grade of inflammation [41][42][43][44][45][46]. In mice, macrophages do not express MPO; only neutrophils do [47,48].…”
Section: Altered Neutrophil Influx In Mmp7 −/− Micementioning
confidence: 99%
“…In patients with lower gastrointestinal symptoms, faecal calprotectin and lactoferrin have been found to be equally recommendable. 13 Lactoferrin is more stable than calprotectin 14 and may be the marker of choice where delay in transit to the laboratory is anticipated.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, stool samples of 7 patients and serum samples of 11 patients (stool sample size = 10; serum sample size = 34) were collected at the onset of GvHD and in the further progression of GvHD every 2-14 d. S100A8/ S100A9 concentrations in the stool were determined using calprotectin assay (Buehlmann). For S100A12 detection, ∼100 mg stool samples were suspended in extraction buffer at 1:50 dilution for homogenization, as described and validated previously (34,39,40). Concentrations of S100A8/ S100A9 and S100A12 in the serum were determined by double-sandwich ELISA, as described previously (34,41).…”
Section: S100 Elisamentioning
confidence: 99%